Stock listing
GERN Stock Price, News, Filings & Events — Geron Corporation
Selected listing: GERN · NASDAQ · USD · US
This page tracks Geron Corporation's GERN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GERN:NASDAQ. GERN:NASDAQ is the stock-level entry point for investors researching Geron Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Geron Corporation, trading under the ticker GERN, is a public company based in the United States with a market capitalization of approximately $911 million. The company focuses on developing innovative therapies for cancer treatment. Geron is committed to advancing its research and development efforts to address unmet medical needs in oncology.
- Ticker
- GERN:NASDAQ
- Asset type
- Stock
- Market cap
- $970.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Geron Corporation GERN:NASDAQ stock context
This page tracks Geron Corporation's GERN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GERN:NASDAQ. GERN:NASDAQ is the stock-level entry point for investors researching Geron Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Geron Corporation, trading under the ticker GERN, is a public company based in the United States with a market capitalization of approximately $911 million. The company focuses on developing innovative therapies for cancer treatment. Geron is committed to advancing its research and development efforts to address unmet medical needs in oncology.
Latest news from Geron Corporation
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 5, 2026
Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Geron Announces Appointment of Chinmaya Rath as Chief Business Officer
July 13, 2026
Geron Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
June 19, 2026
Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
June 1, 2026
Geron Corporation earnings calls
Geron Corporation (GERN) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Geron Corporation (GERN) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Geron Corporation (GERN) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Geron Corporation (GERN) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Geron Corporation (GERN) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Geron Corporation (GERN) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Geron Corporation
Geron Corporation investor report
Review AI stock analysis and investor report context for GERN:NASDAQ.
Geron Corporation company profile
View the public company page for Geron Corporation on 6ix.
Geron Corporation news
Read company news and market updates connected to Geron Corporation.
Geron Corporation investor events
Find investor webinars, events, and replay context for Geron Corporation.
Alternate listings
GON:TRADEGATE
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
GON:GETTEX
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
GON:DUS
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
GERN:BOATS
US · USD
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
902213:LS
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
902213:LSX
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
1GERN:MIL
IT · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
0IV3:LSE
GB · USD
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
GON:HAM
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
GON:SWB
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
GON:BX
CH · CHF
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.
GON:FWB
DE · EUR
Alternate listing for Geron Corporation; the primary context on this page is GERN:NASDAQ.